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A B S T R A C T
The gastrointestinal (GI) tract can play a critical role in the development of pathologies associated with over-
eating, overweight and obesity. We previously observed that supplementation with anthocyanins (AC) (parti-
cularly glycosides of cyanidin and delphinidin) mitigated high fat diet (HFD)-induced development of obesity,
dyslipidemia, insulin resistance and steatosis in C57BL/6J mice. This paper investigated whether these beneficial
effects could be related to AC capacity to sustain intestinal monolayer integrity, prevent endotoxemia, and HFD-
associated dysbiosis. The involvement of redox-related mechanisms were further investigated in Caco-2 cell
monolayers. Consumption of a HFD for 14 weeks caused intestinal permeabilization and endotoxemia, which
were associated with a decreased ileum expression of tight junction (TJ) proteins (occludin, ZO-1 and claudin-1),
increased expression of NADPH oxidase (NOX1 and NOX4) and NOS2 and oxidative stress, and activation of
redox sensitive signals (NF-κB and ERK1/2) that regulate TJ dynamics. AC supplementation mitigated all these
events and increased GLP-2 levels, the intestinal hormone that upregulates TJ protein expression. AC also
prevented, in vitro, tumor necrosis factor alpha-induced Caco-2 monolayer permeabilization, NOX1/4 upregu-
lation, oxidative stress, and NF-κB and ERK activation. HFD-induced obesity in mice caused dysbiosis and af-
fected the levels and secretion of MUC2, a mucin that participates in intestinal cell barrier protection and im-
mune response. AC supplementation restored microbiota composition and MUC2 levels and distribution in HFD-
fed mice. Thus, AC, particularly delphinidin and cyanidin, can preserve GI physiology in HFD-induced obesity in
part through redox-regulated mechanisms. This can in part explain AC capacity to mitigate pathologies, i.e.
insulin resistance and steatosis, associated with HFD-associated obesity.
1. Introduction
The gastrointestinal (GI) tract plays a major role in sustaining
human health and alterations in GI tract physiology are associated with
systemic effects that can contribute to the development of various
pathologies [1]. Malnutrition, e.g. high fat diets, overweight, and
obesity, affect intestinal function and are known to contribute to the
development of insulin resistance, type 2 diabetes (T2D), and non-al-
coholic fatty liver disease (NAFLD), among other pathological condi-
tions [2–6].
Intestinal health is in part determined by a functional intestinal
barrier, an appropriate microbiota, and controlled levels of
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inflammation. These three components of intestinal physiology are in-
terrelated: i) intestinal permeabilization can lead to the paracellular
transport of endotoxins present in food or those generated by the lu-
minal microbiota, which once in the circulation, can trigger systemic
inflammatory responses [5,7,8]; ii) modifications in microbiota com-
position can affect intestinal barrier function, endotoxin production,
and the synthesis of trophic and energy-regulating hormones [9–12];
and iii) in a mutualistic relationship, the immune system and the mi-
crobiota interact to sustain intestinal health [13,14]. Given the role of
the gastrointestinal tract on energy homeostasis, restoration and/or
conservation of integrity of the intestinal barrier and microbial balance
may be effective strategies for optimizing metabolism, and prevent the
development of metabolic dysregulation and associated pathologies.
Dietary bioactives can have a major influence on GI tract function,
and subsequently, on its impact on overall health. Select flavonoids
have multiple actions at the level of the GI tract that could explain the
systemic effects associated with their consumption [10,15]. Several
health benefits have been attributed to the flavonoid subfamily of an-
thocyanins (AC). With regard to the GI tract, we previously observed
that AC protected in vitro Caco-2 intestinal cell monolayers from tumor
necrosis alpha (TNFα)-induced permeabilization [16]. This effect was
dependent on AC structure, cyanidin and delphinidin being the most
effective. A subsequent in vivo study showed that supplementing the
diet with a berry extract rich in both cyanidin and delphinidin miti-
gated high fat diet (HFD)-induced development of obesity, dyslipi-
demia, insulin resistance and steatosis in C57BL/6J mice [17]. We
observed that AC modulated cell redox conditions, decreasing the ex-
pression of select NADPH oxidases and attenuating oxidative stress and
redox-regulated signaling pathways, e.g. NF-κB and mitogen activated
protein kinases (MAPKs).
This paper investigated whether the previously reported beneficial
effects of supplementation with cyanidin and delphinidin mitigating
insulin sensitivity and steatosis in HFD-fed C57BL/6J mice [17] could
be in part due to their protective actions on intestinal monolayer in-
tegrity, endotoxemia, and modulation of the associated dysbiosis. The
involved mechanisms were further investigated in vitro in Caco-2 cell
monolayers. Cyanidin and delphinidin protected the monolayer in-
tegrity by preventing the loss of tight junction (TJ) structure and
function. These effects seem to occur in part via the modulation of
NADPH oxidase expression, prevention of oxidative stress, and down-
stream, inhibition of NF-κB, and of the MAPK ERK1/2 pathways. Si-
multaneously, AC acted by stimulating the production of the GI trophic
hormone GLP-2 and restoring the normal composition of the micro-
biota.
2. Materials and methods
2.1. Materials
Caco-2 cells were from the American Type Culture Collection
(Rockville, MA). Cell culture media and reagents were from Invitrogen/
Life Technologies (Grand Island, NY). HBSS 1X (21-022-CV) was ob-
tained from Corning (Manassas, VA). The Millicell cell culture inserts
were from EMD Millipore (Hayward, CA). Human interferon gamma
(IFN-γ) and primary antibodies for β-actin (#12620), phosphor
(Ser536) p65 (#3033), p65 (3987), phosphor (Thr202/Tyr204) ERK1/2
(#4370), ERK1/2 (#9102), and phosphor (Thr18/Ser19) MLC (#3671)
were from Cell Signaling Technology (Danvers, MA). Antibodies for
HSC-70 (SC-1059), and nitric oxide synthase 2 (NOS2) (sc-649) were
from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies for
ZO-1 (33–9100), occludin (71–1500), and claudin-1 (71–7800) were
from Invitrogen (Carlsbad, CA). Antibodies for 4-hydroxynonenal (4-
HNE) (ab46545), NOX4 (ab216654) and NOX1 (ab55831) were from
Abcam Inc. (Cambridge, MA). PVDF membranes were obtained from
BIO-RAD (Hercules, CA, USA). The Enhanced chemiluminescence (ECL)
Western blotting system was from Thermo Fisher Scientific Inc.
(Piscataway, NJ). Fluorescein isothiocyanate (FITC)-dextran (4 kDa),
protocatechuic acid (PCA), and all other chemicals were purchased
from Sigma-Aldrich Co (St. Louis, MO). Endotoxin levels were de-
termined using a kit from Lonza (Basel, Switzerland). GLP-2 was de-
termined using a kit from Crystal Chem Inc (Downers Grove, IL). The
AC-rich mix was provided by NSE Products, Inc. (Provo, UT) and its
composition is described in Ref. [17]. Delphinidin-3-O-glucoside, cya-
nidin-3-O-glucoside, and peonidin-3-O-glucoside were from Extra-
synthese (Genay Cedex, France).
2.2. Animals and animal care
All procedures were in agreement with standards for care of la-
boratory animals as outlined in the NIH Guide for the Care and Use of
Laboratory Animals; experimental protocols were approved before
implementation by the University of California, Davis Animal Use and
Care Administrative Advisory Committee. Procedures were adminis-
tered under the auspices of the Animal Resource Services of the
University of California, Davis.
Healthy male C57BL/6J mice (20–25 g) (10 mice/group) were fed
for 14 w either: i) a diet containing approximately 10% total calories
from fat (Control, C group); ii) the control diet plus 40mg AC/kg body
weight (CA group); iii) a diet containing approximately 60% total cal-
ories from fat (lard) (HF group); or iv) the high fat diet supplemented
with 40mg AC/kg body weight (HFA40 group). Considering the dose
translation from animals to humans [18], the amount of AC consumed
by mice in the current study corresponds to a human equivalent intake
of 225mg of AC per day. Although average daily consumption of AC is
lower in human populations, a cup of berries would provide similar
amounts (e.g. 240 and 175mg AC per 100 g of raw blueberries and
blackcurrants, respectively).
After 14 weeks on the dietary treatments, mice were euthanized by
cervical dislocation. Blood from the submandibular vein was collected
into heparinized tubes, and plasma isolated after centrifugation at
3,000×g for 10min at room temperature. The intestine was dissected,
measured, divided into its different portions (duodenum, jejunum,
ileum and colon). Tissues were rinsed with PBS containing protease
inhibitors, flash frozen in liquid nitrogen, and then stored at −80 °C
until further analysis. The overall metabolic profile of these animals has
been recently published [17]. Plasma GLP-2 and endotoxin concentra-
tions were determined following the manufacturer's protocols.
2.3. Intestinal permeability
Intestinal permeability was measured after 8 weeks on the diets as
described previously [10]. Mice were fasted for 4 h then gavaged with
FITC-dextran 4 kDa (200mg/kg body weight). After 90min, 100 μl of
blood was collected from the tip of the tail vein. The blood was kept in
the dark and centrifuged at 3,000×g for 10min at room temperature,
and the serum collected. Serum aliquots (20 μl) and a standard curve of
FITC-dextran were plated in 96-well plates and diluted to 200 μl with
0.9% (w/v) NaCl. Fluorescence was measured using a microplate
spectrofluorometer (Synergy H1, BioTek, Winooski, USA) at λexc:
495 nm and λem: 520 nm.
2.4. Cell culture and incubations
Caco-2 cells were cultured at 37 °C and 5% (v/v) CO2 atmosphere in
minimum essential medium (MEM) supplemented with 10% (v/v) fetal
bovine serum, antibiotics (50 U/ml penicillin, and 50 μg/ml strepto-
mycin), 1% (v/v) of 100X non-essential amino acids, and 1mM sodium
pyruvate. The medium was replaced every 3 d during cell growth and
differentiation. For the experiments, cells were used 18 d after reaching
confluence to allow for differentiation into intestinal epithelial cells.
Cells were used between passages 3 and 15. All the experiments were
performed in serum- and phenol red-free MEM.
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2.5. Evaluation of Caco-2 monolayer permeability
Caco-2 monolayer permeability was evaluated by measuring the
transepithelial electrical resistance (TEER) and the paracellular trans-
port of FITC-dextran as previously described [16]. For both methods,
cells were differentiated into polarized monolayers. For the evaluation
of TEER and FITC-dextran permeability, Caco-2 cell monolayers were
preincubated for 24 h with IFNγ (10 ng/ml) to upregulate the TNFα
receptor [19]. The monolayers were then incubated for 30min with the
AC mix, protocatechuic acid (PCA), or the 3-O-glucosides of cyanidin,
delphinidin or peonidin added to the upper compartment. To promote
monolayer permeabilization, monolayers were treated with TNFα
(5 ng/ml) added to the lower chamber. Cells were incubated for 6 h
further for TEER evaluation or 9.5 h for FITC-dextran permeability
determination. TEER was measured using a Millicell-ERS Resistance
System (Millipore, Bedford, MA) that includes a dual electrode volt-
ohm-meter. TEER was calculated as: TEER = (Rm – Ri) x A(Rm, trans-
membrane resistance; Ri, intrinsic resistance of a cell-free media; and A,
the surface area of the membrane in cm2). The apical-to-basolateral
clearance (CL) of FITC-dextran (4 kDa) was calculated using the equa-
tion fFITC/(FFITC/A), where fFITC is the flux of FITC-dextran (in fluores-
cence units/h); FFITC, the fluorescence of FITC-dextran in the upper
compartment at zero time (in fluorescence units per nl); and A, the
surface area of the membrane (1 cm2). Arbitrary units (AU) were cal-
culated based on TEER or CL values for the non-added (control) cells.
2.6. Western blot analysis
Homogenates were prepared in lysis buffer containing 4x amount of
protease inhibitors using a bead tissue homogenizer (Bead Mill 24,
Fisher Scientific, Waltham, MA). Aliquots of total homogenates con-
taining 30 μg protein were denatured with Laemmli buffer, separated
by reducing 10% polyacrylamide gel electrophoresis, and electroblotted
onto PVDF membranes. Membranes were blocked for 1 h in 5% (w/v)
defatted milk and subsequently incubated in the presence of the cor-
responding primary antibody (1:1,000 dilution) overnight at 4 °C. After
incubation for 90min at room temperature in the presence of the cor-
responding secondary antibody (HRP conjugated) (1:10,000 dilution),
the conjugates were visualized uding an ECL system in a
Phosphoimager 840 (Amersham Pharmacia Biotech. Inc., Piscataway,
NJ).
2.7. Immunohistochemistry
Immunohistochemistry (IHC) of ileum samples was done as pre-
viously described [10]. Tissues were fixed in 4% (w/v) solution of
paraformaldehyde in PBS overnight, rinsed with PBS and stored in 70%
(v/v) ethanol. Samples were embedded in paraffin and 5 μm sections
were obtained. Once deparaffinized, sections were processed for an-
tigen retrieval by incubation in 10mM sodium citrate buffer (pH 6.0)
containing 0.05% (v/v) Tween 20 at 95 °C for 10min, washed twice
with 0.1% (v/v) Triton X-100 in PBS, blocked for 45min in 2% (v/v)
donkey serum in 0.1% (v/v) Triton X-100 in M PBS, and incubated
overnight at 4 °C with primary antibody for MUC2 (1:200). Sections
were washed in PBS and incubated for 2 h at room temperature with
Cy3-conjugated donkey anti-mouse or anti-rabbit IgG (1:500) (Jackson
ImmunoResearch Co. Laboratories West Grove, PA). After im-
munostaining, cell nuclei were stained with 1 μg/ml Hoechst 33342 and
sections were imaged using an Olympus FV 1000 laser scanning con-
focal microscope (Olympus, Japan). Olympus Fluoview version 4.0
software was used to merge images. Four slices per animal and four
animals from each group were analyzed.
2.8. Microbiota analysis
Cecum content samples were collected in sterile tubes for
subsequent investigation of the microbiome through high throughput
sequencing. Samples were stored at −80 °C until processing for DNA
extraction. Genomic DNA was extracted from cecal samples using the
Zymo Research Fecal DNA Miniprep Kit per the manufacturer's in-
structions (Zymo Research, Irvine, CA, USA). The V4 region of the 16S
rRNA gene was amplified by targeted barcoded primers F515 (5′-NNN
NNNNNGTGTGCCAGCMGCCGCGGTAA-3′) and R806 (5′-GGACTACH-
VGGGTWTCTAAT-3′) as previously described [20]. Amplicons were
then pooled and purified with the QIAquick PCR Purification Kit
(Qiagen, Germantown, MD, USA) and taken to the UC Davis Genome
Center DNA Technologies Sequencing Core for library preparation and
paired-end sequenced on an Illumina Miseq. PEAR [21] was used to
merge the paired end reads and they were subsequently demultiplexed
using the FASTX Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/).
Cutadapt was then used to trim off barcodes and primers from reads
[22]. Read quality filtering, OTU picking using the implemented swarm
method, filtering the OTU table, rarefaction, and beta diversity data
analysis was carried out within the QIIME software package (University
of Colorado, Boulder, CO, USA. version 1.9.1) [23]. Swarm was used
within the QIIME package as the operational taxonomic unit clustering
method [24]. Beta diversity metrics were calculated based on Unifrac
distances. Results were visualized by nonmetric multidimensional
scaling (NMDS) as implemented in the vegan package in R.
3. Statistical analysis
Data were analyzed by one-way analysis of variance (ANOVA) using
Statview 5.0 (SAS Institute Inc., Cary, NC). Fisher least significance
difference test was used to examine differences between group means.
A p value < 0.05 was considered statistically significant. Data are
shown as mean ± SE.
4. Results
4.1. Supplementation with AC improved HFD-associated increased
intestinal permeability and endotoxemia
As previously described [17], consumption of the HFD for 14 weeks
resulted in obesity and insulin resistance in C57BL/6J mice, which were
mitigated by AC supplementation. Although no significant changes
were observed in the small intestine length and weight (data not
shown); the colon weight and the colon weight/length ratio were
higher in HF compared to C and CA mice (Fig. 1A). AC supplementation
mitigated the increased colon weight/length ratio associated with HFD
consumption.
Intestinal permeability was evaluated by measuring the paracellular
transport of FITC-dextran after 8 weeks on the corresponding diets.
FITC-dextran transport was five times higher in mice consuming the
HFD compared to controls, but this higher level was not observed in the
HFA group (Fig. 1B). An increase in intestinal permeability can lead to
the paracellular transport of luminal endotoxins into the circulation. In
agreement with FITC-dextran results, plasma endotoxin levels were
98% higher in HF compared to C and CA mice (Fig. 1C). In mice fed the
HFD and supplemented with AC, plasma endotoxin concentrations were
similar to control values.
4.2. AC prevented TNFα-induced permeabilization of Caco-2 cell
monolayers
We next investigated if the AC mix fed to mice could also inhibit in
vitro the permeabilization of Caco-2 cell monolayers. Permeabilization
was induced by exposure to a pro-inflammatory challenge (TNFα) and
was evaluated by measuring the paracellular transport of FITC-dextran
and the monolayer TEER. Incubation in the presence of TNFα in the
lower chamber (basolateral side) caused a 1.1-fold increase in FITC-
dextran paracellular transport and a 32% decrease in TEER (Fig. 2A and
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B). Addition of the AC mix to the upper chamber (apical side) fully
prevented the increase in FITC-dextran permeability at both, 2.5 and
5 μg AC mix/ml, and the decrease in TEER at the highest AC mix con-
centration tested (5 μg AC/ml).
We subsequently tested the capacity of individual AC and PCA at
approximately the concentrations present in 5 μg mix/ml (1 μM cya-
nidin, 0.5 μM delphinidin, 0.1 μM peonidin, and 0.5 μM PCA) to prevent
TNFα-induced Caco-2 monolayer permeabilization. PCA and the 3-O-
glucosides of cyanidin and delphinidin, but not peonidin, inhibited the
paracellular transport of FITC-dextran (Fig. 2C) and the decrease in
TEER (Fig. 2D) promoted by TNFα.
4.3. AC prevented HFD-mediated alterations in TJ protein expression and
modulated GLP-2
As previously observed [10], consumption of the HFD for 14 weeks
was associated with an altered expression of TJ proteins in the ileum. In
HF mice, a 50, 73 and 44% decrease in ileum occludin, ZO-1 and
claudin-1 protein levels was observed compared to controls as mea-
sured by Western blot. Supplementation of HFD-fed mice with AC ei-
ther partially (ZO-1) or fully (occludin and claudin-1) inhibited HFD-
mediated decreases in TJ protein expression (Fig. 3 A).
GLP-2 is an intestinal hormone that has important trophic and TJ
protective functions at the intestinal epithelium. Mice supplemented
with AC showed a significant increase in plasma GLP-2 levels compared
to control and HF mice. In AC40 and HFA40 mice plasma GLP-2 con-
centrations were 2- and 1.4-fold higher than in non-supplemented
controls (Fig. 3B).
4.4. AC modulated signaling pathways and redox-related events that affect
TJ structure and function
Both the NF-κB and ERK1/2 pathways are involved in the mod-
ulation of TJ structure and function. To evaluate the activation of these
cascades we measured the phosphorylation of p65 (NF-κB) and ERK1/2
by Western blot. p65 and ERK1/2 phosphorylation levels were 54 and
47% higher in HF mouse ileum compared to controls (Fig. 4A).
Downstream, ileum myosin light chain (MLC) phosphorylation levels
were 60% higher in the HF than in controls. Supplementation with AC
prevented HFD-associated increases in p65, ERK1/2 and MLC phos-
phorylation (Fig. 4A).
Given that the upregulation of NADPH oxidases NOX1 and NOX4
and oxidative stress are observed in association with intestinal per-
meabilization in HFD-fed mice [9], we next investigated the capacity of
AC supplementation to mitigate NADPH oxidases and inducible nitric
oxide synthase (NOS2) upregulation, and the occurrence of ileum oxi-
dative damage by measuring 4-HNE-protein adducts. NOX1, NOX4 and
NOS2 protein levels were higher in HF ileum (60, 40 and 81%,
Fig. 1. Effects of AC supplementation on HFD-
mediated changes on colon weight and length,
and intestinal permeability in mice.Mice were fed
a control diet (empty bars), the control diet supple-
mented with 40mg AC/kg body weight (dashed
bars), a HFD (black bars), or the HFD supplemented
with 40mg AC /kg body weight (blue bars) for 14
weeks. A- Colon weight, length and weight/length
ratio. B,C- Intestinal permeability was evaluated by
measuring at week 8 on the diets, FITC-dextran
permeability (B), and at week 14, plasma endotoxin
(C). Results are shown as means ± SE and are the
average of 9–10 animals/group. Values having dif-
ferent superscripts are significantly different
(p < 0.05, One-way ANOVA test). (For interpreta-
tion of the references to colour in this figure legend,
the reader is referred to the Web version of this ar-
ticle.)
E. Cremonini, et al. Redox Biology 26 (2019) 101269
4
respectively) than in controls and HFA mice (Fig. 4B). This was asso-
ciated with a 40% increase in 4-HNE-protein adducts corresponding to
the 40 kDa protein band. AC supplementation mitigated HFD-triggered
NADPH oxidases (NOX1 and NOX4) and NOS2 upregulation, and the
increased 4-HNE-protein adducts levels.
4.5. Effects of cyanidin, delphinidin, peonidin and PCA on TNFα-induced
NF-κB and ERK1/2 activation, NADPH oxidase upregulation, and oxidative
stress in Caco-2 cells
NF-κB and ERK signaling pathways are activated downstream of
TNFα binding to its receptor and are major players in TNFα-induced
permeabilization of the intestinal barrier. In Caco-2 cells, exposure to
TNFα increased the phosphorylation of NF-κB (p65), ERK 1/2 (49 and
160%, respectively), and MLC (59%), compared to controls (Fig. 5A).
At the tested concentrations, PCA, cyanidin-3-O-glucoside and the AC
mix, fully prevented p65, ERK1/2, and MLC phosphorylation. Delphi-
nidin-3-O-glucoside inhibited TNFα-triggered p65 phosphorylation,
and peonidin3-O-glucoside had no effect on these parameters. On the
other hand, PCA, cyanidin, peonidin and the AC mix inhibited TNFα-
mediated NOX1 and NOX4 upregulation, and prevented 4-HNE-protein
adduct formation, a marker of protein/lipid oxidation (Fig. 5B).
Fig. 2. Effects of the AC-rich mix, PCA, and 3-O-
glucosides of cyanidin, delphinidin, and peo-
nidin on TNFα-induced permeabilization of Caco-
2 cell monolayers. Caco-2 cell monolayers were pre-
incubated for 24 h with IFNγ (10 ng/ml) to upregu-
late the TNFα receptor. Then, the following com-
pounds were added to the upper chamber and cells
incubated for 30min: A,B- 0.5–5 μg AC mix/ml or
C,D- the concentration of the individual components
present in the mix at a 5 μg AC/ml concentration:
0.5 μM PCA, 1 μM cyanidin-3-O-glucoside, 0.5 μM
delphinidin-3-O-glucoside, or 0.1 μM peonidin.
TNFα (5 ng/ml) was subsequently added to the lower
chamber and cells incubated for further 6 h. Caco-
2 cell monolayer permeability was evaluated by
measuring (A,C) FITC-dextran paracellular transport
(FITC-Dextran) and (B,D) TEER. Basal TEER values
were 350–420Ω cm2 and basal average FITC-dextran
clearance value was 65 nl. h−1.cm−2. Results are
shown as mean ± SE of 4–6 independent experi-
ments. Results (A.U.: arbitrary units) were normal-
ized to control values (1, dashed line). Values having
different superscripts are significantly different
(p < 0.05, One-way ANOVA).
Fig. 3. AC mitigates HFD-mediated decrease in TJ
protein expression and modulates hormones that
regulate TJ structure and function. Mice were fed
a control diet (empty bars), the control diet supple-
mented with 40mg AC/kg body weight (dashed
bars), a HFD (black bars), or the HFD supplemented
with 40mg AC /kg body weight (blue bars) for 14
weeks. A- Ileum protein levels of occludin, ZO-1 and
claudin-1 were measured by Western blot. Bands
were quantified and values normalized to HSC70
levels (loading control). Values were referred to
those of the control group (empty bars). B- Plasma
GLP-2 concentrations were measured by ELISA.
Results are shown as mean ± SE of 6–8 animals/
treatment. Values having different superscripts are
significantly different (p < 0.05, One-way ANOVA
test). (For interpretation of the references to colour
in this figure legend, the reader is referred to the
Web version of this article.)
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Fig. 4. Effects of AC on signaling molecules that
regulate TJ structure and function, on the upre-
gulation of ileum NADPH oxidases and NOS2,
and on protein oxidation induced by HFD con-
sumption in mice. A- Phosphorylation levels of p65
(Ser536), ERK1/2 (Thr202/Tyr204) and MLC
(Ser19) in total ileum homogenates were measured
by Western blot. Bands were quantified and values
normalized to non-phosphorylated protein levels. B-
Total protein levels of NOX1, NOX4, NOS2 and 4-
HNE-protein adducts (MW: 40 kDa). Proteins were
measured by Western blot in the ileum of mice fed a
control diet (empty bars), the control diet supple-
mented with 40mg AC/kg body weight (dashed
bars), a HFD (black bars), or the HFD supplemented
with 40mg AC /kg body weight (blue bars) for 14
weeks. Bands were quantified and values normalized
to HSC70 levels (loading control). Results were re-
ferred to those of the control group (C). Results are
shown as mean ± SE of 6–8 animals/treatment.
Values having different superscripts are significantly
different (p < 0.05, One-way ANOVA test). (For
interpretation of the references to colour in this
figure legend, the reader is referred to the Web ver-
sion of this article.)
Fig. 5. Effects of AC on TNFα-induced upregulation of signals that regulate TJ structure and the associated upregulation of NADPH oxidases and protein/
lipid oxidation in Caco-2 cells. Caco-2 cells were incubated for 6 h at 37 °C in the absence of additions (control, C) (empty bars); or after addition of 5 ng/ml TNFα
in the absence (TNFα) (black bars) or the presence of 0.5 μM PCA (grey bars); 1 μM cyanidin-3-O-glucoside (dotted bars), 0.5 μM delphinidin-3-O-glucoside (dashed
bars), 0.1 μM peonidin (white bars) or 5 μg AC/ml (light blue bars). A- Phosphorylation levels of p65 (Ser536), ERK1/2 (Thr202/Tyr204), and MLC (Ser19), and B-
total protein levels of NOX1, NOX4, and 4-HNE-protein adducts (MW: 40 kDa) were measured by Western blot. Bands were quantified and values normalized to (A)
the non-phosphorylated protein and B- β-actin levels. Results were referred to control group values (C). Results are shown as mean ± SE of 6 independent ex-
periments. Values having different superscripts are significantly different (p < 0.05, One-way ANOVA test). (For interpretation of the references to colour in this
figure legend, the reader is referred to the Web version of this article.)
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Interestingly, the AC mix and cyanidin-3-O-glucoside decreased the
levels of 4-HNE-protein adducts at lower levels than those of control (no
TNFα added) cells.
4.6. AC prevented the adverse effects of HFD consumption on MUC2
secretion from goblet cells
MUC2 is a major component of the mucus layer that protects the
intestinal epithelium monolayer and constitutes the first line of im-
munological defense [25]. We next measured the amount and dis-
tribution of MUC2 in mouse ileum. MUC2 protein levels measured by
Fig. 6. AC mitigates HFD-mediated alterations in MUC2 levels and dis-
tribution in mouse ileum. Mice were fed a control diet (empty bars), the
control diet supplemented with 40mg AC/kg body weight (dashed bars), a HFD
(black bars), or the HFD supplemented with 40mg AC /kg body weight (blue
bars) for 14 weeks. A- The ileum content of MUC2 was measured by Western
blot. Bands were quantified and values referred to HSC70 levels (loading con-
trol). Results were referred to those of the control group (C). Results are shown
as mean ± SE of 6–8 animals/treatment. Values having different superscripts
are significantly different (p < 0.05, One-way ANOVA test). B- Representative
images for immunohistochemistry and confocal microscopy for MUC2 (red
fluorescence). Nuclei were stained with Hoechst (blue fluorescence) (Bar:
50 μm). (For interpretation of the references to colour in this figure legend, the
reader is referred to the Web version of this article.)
Fig. 7. AC prevents HFD-induced alterations in mouse cecal microbiota.
Mice were fed a control diet (red dots, empty bars), the control diet supple-
mented with 40mg AC/kg body weight (green dots, dashed bars), a HFD (blue
dots, black bars), or the HFD supplemented with 40mg AC /kg body weight
(violet dots, blue bars) for 8 weeks. A- Changes in cecum microbiota were as-
sessed by clustering of samples based on diet. NMDS was performed based on
the weighted UniFrac distance matrix generated from sequencing fecal 16S
rRNA gene The X-axis represents the tertiary coordinate, the Y-axis represents
the secondary coordinate. Axis numbering represents the relative distance be-
tween samples based on the weighted UniFrac distance matrix. B- Ratio of fecal
Firmicutes/Bacteroidetes abundance, and C- fecal Akkermansia relative abun-
dance. B,C- Results are shown as mean ± SE of 6–10 animals/treatment.
Values having different superscripts are significantly different (p < 0.05, One-
way ANOVA test). (For interpretation of the references to colour in this figure
legend, the reader is referred to the Web version of this article.)
E. Cremonini, et al. Redox Biology 26 (2019) 101269
7
Western blot were 33% lower in HF than in control and HFA mice
(Fig. 6A). IHC characterization of MUC2 distribution showed that
consumption of the HFD caused the accumulation of MUC2 in Goblet
cells, which was prevented by AC supplementation (Fig. 6B)
4.7. AC affects the composition of the microbiota both in control- and HFD-
fed mice
Long-term consumption of a HFD affects the composition of the
microbiota. Overall evaluation of cecal microbiota profiles was done by
nonmetric multidimensional scaling (NMDS). After 8 weeks on the
corresponding diets, the microbiota of HF mice clustered separately
from that of control mice (Fig. 7 A), while HFD-fed mice supplemented
with AC showed a clustering similar to that of controls. Interestingly,
the fecal microbiota from mice fed the control diet supplemented with
AC showed a clear cluster separation compared to unsupplemented
controls.
Among the microbiota changes associated with HFD consumption,
we found the widely described increase in the ratio Firmicutes/
Bacteroidetes (Fig. 7B), and also a 50% decrease in Akkermansia relative
abundance (Fig. 7C). AC supplementation prevented both the altered
Firmicutes/Bacteroidetes ratio and the decrease in Akkermansia relative
abundance.
5. Discussion
Chronic consumption of a HFD by C57BL/6J mice caused intestinal
permeabilization, endotoxemia, and dysbiosis, which were prevented
by AC dietary supplementation. AC modulated key events that regulate
epithelial cell monolayer permeability and endotoxemia, i.e. NADPH
oxidase upregulation, oxidative stress, NF-κB and ERK1/2 activation,
and downstream MLC phosphorylation. Furthermore, AC supple-
mentation was associated with increased plasma GLP-2 concentrations,
and mitigation of HFD-mediated impaired MUC2 secretion and dys-
biosis. The above AC beneficial effects can all contribute to the pro-
tection of intestinal barrier function, prevention of endotoxemia and
enhancement of metabolic control.
The present work is an extension of a previous study in which, using
the same set of mice, we observed that AC (cyanidin and delphinidin)
supplementation, mitigates the development of insulin resistance, liver
inflammation and steatosis in mice fed a high fat diet [17]. Mechan-
istically, these AC-mediated protective actions were associated with the
inhibition of upregulation of NADPH oxidases, oxidative stress, and
activation of redox-sensitive signaling (JNK, NF-κB) in liver and adipose
tissue [17]. In the current study, we observed that the AC supple-
mentation prevented HFD-mediated intestinal permeabilization and
endotoxemia, which can both explain findings of local (ileal NF-κB
activation and NOS2 upregulation) and systemic inflammation [17]. In
agreement with previous findings, both in vivo and in vitro, the AC mix
and the major individual components, i.e. cyanidin, delphinidin and
PCA, but not peonidin, protected Caco-2 cell monolayers from TNFα-
induced permeabilization [16]. Stressing the physiological relevance of
these findings, the concentrations of AC affording full protection
against TNFα-induced Caco-2 monolayer permeabilization are more
than 10 times lower than those found in human ileum after consump-
tion of 300 g of raspberries [26]. Intestinal permeabilization allows the
passage into the circulation of pro-inflammatory bacterial components,
including endotoxins. This is proposed to underlie in part obesity- and
Western style diet-associated pathologies, including T2D and NAFLD
[2,5,27–29]. Thus, mitigation of intestinal permeabilization may con-
tribute to the beneficial actions of AC on diet-induced obesity, insulin
resistance, and steatosis.
The intestinal epithelium is a single cell layer composed of different
cell types with multiple functions, forming a barrier between the ex-
ternal environment and the body [7]. Monolayer permeabilization can
be due to HFD and/or inflammation-induced alterations in expression
of specific TJ components which are determinants of the functionality
of the intestinal barrier. In this regard, both dietary fat and the asso-
ciated increase in bile acid production contribute to suppression of TJ
protein expression (claudin-1, claudin-3, occludin and junctional ad-
hesion molecule-1) and to intestinal permeabilization in rats [30]. We
observed that the chronic consumption of a HFD decreased the ex-
pression of ZO-1, occludin and claudin-1 in the ileum of C57BL/6J
mice. These alterations were partially or completely prevented by AC,
providing a mechanism to in part explain AC capacity to prevent in-
testinal permeabilization and endotoxemia in vivo. These effects of AC
were similar to those observed in mice fed a HFD and supplemented
with the flavanol (−)-epicatechin [10]. It is important to consider that
the chemical structure of cyanidin, delphinidin, PCA, and (−)-epica-
techin includes a free 3′-hydroxyl group in the B ring that is methylated
in peonidin. Therefore, it can be speculated that the bioactivity of
certain ACs and flavanols may rely on the catechol structure of the B-
ring.
NF-κB and ERK1/2 are activated by oxidative stress [31–33] and it
has been reported previously that H2O2 moderately activates ERK1/2 in
Caco-2 cells [34] and causes MDCK cell monolayer permeabilization in
a ZO-1 and ERK1/2-dependent manner [35]. In addition, H2O2 acti-
vates NF-κB in Caco-2 cells leading to an increased expression of NOS2,
and oxidation/nitration of cytoskeletal proteins [36]. Compounds, i.e.
(−)-epicatechin and apocynin, that inhibit the superoxide/H2O2-gen-
erating NADPH oxidase activity/expression and prevent protein/lipid
oxidation, were able to concurrently mitigate TNFα-induced Caco-2 cell
monolayer permeabilization [10,37] and HFD-induced intestinal per-
meabilization and endotoxemia in mice [10]. In the present study, we
observed that AC supplementation prevented the upregulation of NOX1
and NOX4 expression and the associated increase in oxidative damage
(actin-4-HNE adducts) in the ileum of mice fed a HFD. Similar effects
were observed for the mix and for individual AC and PCA in Caco-2
monolayers treated with TNFα. Both NOX1 and NOX4 expression are in
part regulated by NF-κB, with several κB sites present in the promoter
region of both genes [38]. Stressing the association of oxidant pro-
duction with NF-κB activation, the regulation of NOS2 followed the
same pattern as that of NOX1 and NOX4. Thus, our results support the
concept that the prevention of NOX4 and NOX1 upregulation of in-
creased superoxide/H2O2 production and activation of NF-κB and
ERK1/2 are relevant mechanisms involved in the protection of the in-
testinal barrier by AC. Additionally, it should be mentioned that 4-HNE
per se can participate in the development of intestinal chronic in-
flammation contributing to permeabilization and carcinogenesis, par-
ticularly in the context of high fat consumption [39].
Obesity and consumption of high fat diets have a major influence on
intestinal microbiota diversity, representation of bacterial genes and
bacteria composition [40,41], which can result not only in alterations
in proper intestinal function, but in systemic consequences affecting the
physiology of other organs. Chronic HFD consumption is associated
with an increased relative abundance of Firmicutes and a decrease of
Bacteroidetes and Akkermansia [40–42]. Accordingly, we observed an
increased Firmicutes/Bacteroidetes relative abundance ratio and an al-
tered clustering of the microbiota in HFD-fed mice. These changes were
not observed in HFD-fed mice supplemented with AC. It should be
pointed out that there is limited conclusive evidence as to the me-
chanisms explaining how these changes in microbiota are molecularly
associated with optimal physiology. In this paper we investigated two
determinants of intestinal health which are known to be in part
modulated by the microbiota composition, i.e. plasma GLP-2 and ileum
mucus levels.
The HFD did not impact GLP-2-plasma concentrations. However, AC
supplementation to mice fed either the control diet or the HFD caused
an increase in GLP-2 plasma concentrations. Although such increases
could be triggered through other mechanisms, it is well accepted that
the microbiota have a role influencing the release of glucagon-like
peptides, i.e. GLP-1 and GLP-2, by L enteroendocrine cells [43]. This is
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highly relevant to AC-mediated improvement of HFD-induced insulin
resistance and steatosis not only given the intestinal barrier trophic and
protective actions of GLP-2 [44], but also to its capacity to decrease
hepatic lipid deposition and modulate energy homeostasis [45,46].
A mucus layer covers the intestinal epithelium constituting the first
barrier against harmful bacteria, toxins, proteolytic enzymes, and other
substances present in the lumen [47]. This layer is composed of highly
glycosylated proteins, MUC2 being the most abundant. MUC2, as well
as other mucins, are synthesized and released by Goblet cells. Even a
short-term exposure to a high fat diet causes an altered release of MUC2
and its accumulation inside Goblet cells [40]. We observed in the ileum
from HFD-fed mice, the accumulation of MUC2 fluorescence in Goblet
cells and a decreased overall amount of MUC2. Supplementation with
AC prevented cell accumulation of MUC2, and mitigated the HFD-
mediated decrease in MUC2 ileal content. Among the factors regulating
MUC2 synthesis, Akkermansia intestinal abundance is associated with
increased MUC2 production [48]. Thus, the observed prevention by AC
of HFD-mediated decrease of Akkermasia relative abundance may in
part explain AC's capacity to mitigate the ileum MUC2 decrease in HFD-
fed mice.
The inhibition of redox-sensitive signals involved in TJ dynamics/
structure modulation and the downregulation of enzymes generating
superoxide/H2O2 (NOX1/NOX4) and nitric oxide (iNOS) appear to be
relevant to AC capacity to preserve barrier integrity. The conservation
of an appropriate intestinal microbiota composition and function can
also contribute to the observed benefits. Thus, the capacity of AC,
particularly delphinidin and cyanidin, and its metabolite PCA, to pre-
serve GI physiology, is not only relevant locally, but can also contribute
to their capacity to mitigate pathologies, i.e. insulin resistance and
steatosis, triggered by high fat consumption [17].
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